Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
M.D. Anderson Cancer Center
Hoffmann-La Roche
Blueprint Medicines Corporation
NaviFUS Corporation
NaviFUS Corporation
NaviFUS Corporation
Blueprint Medicines Corporation
DNAtrix, Inc.
Second Affiliated Hospital, School of Medicine, Zhejiang University
NaviFUS Corporation
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Yale University
Assistance Publique - Hôpitaux de Paris
Merck Sharp & Dohme LLC